ELK3 and breast carcinoma: We suggest that miR-200a functions as a suppressor of metastatic characteristics by targeting ELK3 in breast cancers, and that the miR-200a/ELK3 axis determines the fate of breast cancer cells whether they are undergoing cell migration, invasion, or metastasis.